| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/06/2009 | US20090196877 Novel Method to Increase Memory T Lymphocytes and Enhance Their Functions |
| 08/06/2009 | US20090196876 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 08/06/2009 | US20090196875 Point mutation analysis of glyceraldehyde-3-phosphate dehydrogenase genes via allele-specific probe hybridization and/or nuclease digestion; kits; drug screening; neurodegenerative disease |
| 08/06/2009 | US20090196874 Anti-tsg101 antibodies and their uses for treatment of viral infections |
| 08/06/2009 | US20090196873 Methods and compositions for treating diseases targeting CDCP1 |
| 08/06/2009 | US20090196872 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 08/06/2009 | US20090196871 Use of 4-pyridylmethylphthalazines for cancer treatment |
| 08/06/2009 | US20090196870 Binding constructs and methods for use thereof |
| 08/06/2009 | US20090196869 Antitumor combinations containing taxane derivatives |
| 08/06/2009 | US20090196868 Methods and compositions for preventing radiation-induced pneumonitis |
| 08/06/2009 | US20090196851 Use of Transcriptome Modifying Agents and Chemotherapy or Radiotherapy Against Cancer |
| 08/06/2009 | US20090196831 Nanostructures, methods of synthesizing thereof, and methods of use thereof |
| 08/06/2009 | US20090196825 Cd38 and obesity |
| 08/06/2009 | US20090196823 Chemokine antagonists as treatment for obesity-related and metabolic syndrome-related conditions |
| 08/06/2009 | CA2714292A1 Heterologous protection against pasteurella multocida provided by p. multocida fur cells and the outer-membrane protein extracts thereof |
| 08/06/2009 | CA2713462A1 Identification of cd8+ t cells that are cd161hi and/or il18r(alpha)hi and have rapid drug efflux capacity |
| 08/06/2009 | CA2712964A1 Tapasin augmentation for enhanced immune response |
| 08/06/2009 | CA2712881A1 Canine influenza vaccines |
| 08/06/2009 | CA2712724A1 Use of lenalidomide or pomalidomide for treating a disease associated with cd59 deficiency |
| 08/06/2009 | CA2712000A1 Stabilized angiopoietin-2 antibodies and uses thereof |
| 08/06/2009 | CA2710534A1 Nucleic acids of formula(1)(nugixmgnnv)a and derivatives thereof as an immunostimulating agent /adjuvant |
| 08/05/2009 | EP2085783A1 Use of NGF inhibitors in breast cancer therapy |
| 08/05/2009 | EP2085468A1 DNA transfection system for the generation of infectious influenza virus |
| 08/05/2009 | EP2085467A2 Lutzomyia Longipalpis polypeptides and methods of use |
| 08/05/2009 | EP2085407A1 Treatment of idiopathic thrombocytopenic purpura |
| 08/05/2009 | EP2085096A2 Novel composition and methods for the treatment of immune related diseases |
| 08/05/2009 | EP2085095A1 Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpart |
| 08/05/2009 | EP2085094A2 Application of aminopeptidases inhibitors and pharmaceutical preparations containing same |
| 08/05/2009 | EP2085090A2 Inhibitors of DNA immunostimulatory sequence activity |
| 08/05/2009 | EP2084275A2 Polypeptide ligands for targeting cartilage and methods of use thereof |
| 08/05/2009 | EP2084190A1 Lingo binding molecules and pharmaceutical use thereof |
| 08/05/2009 | EP2084188A2 Antibodies to lymphotoxin-alpha |
| 08/05/2009 | EP2084185A2 Human antibodies neutralizing human metapneumovirus |
| 08/05/2009 | EP2083868A2 Generation of a cancer-specific immune response toward muc1 and cancer specific muc1 antibodies |
| 08/05/2009 | EP2083865A2 Methods for providing prophylactic surface treatment for fluid processing systems and components thereof |
| 08/05/2009 | EP2083864A2 Antagonists of pcsk9 |
| 08/05/2009 | EP2083863A1 Use of tgf-beta antagonists to treat infants at risk of developing bronchopulmonary dysplasia |
| 08/05/2009 | EP2083862A2 Compositions and methods for treating ocular diseases and conditions |
| 08/05/2009 | EP2083861A2 Antagonists of pcsk9 |
| 08/05/2009 | EP2083860A2 Antagonists of pcsk9 |
| 08/05/2009 | EP2083859A2 Antagonists of pcsk9 |
| 08/05/2009 | EP2083858A2 Human immune therapies using a cd27 agonist alone or in combination with other immune modulators |
| 08/05/2009 | EP2083856A2 Peptides for desensibilization against allergens |
| 08/05/2009 | EP2083855A1 Use of measles virus nucleoprotein for treating atherosclerosis |
| 08/05/2009 | EP2083854A2 Method for stimulating dendritic cells and cell product thus obtained for the autologous immunotherapy of solid human tumours |
| 08/05/2009 | EP2083853A2 Shigella ipad protein and its use as a vaccine against shigella infection |
| 08/05/2009 | EP2083852A1 Tumor immunity |
| 08/05/2009 | EP2083851A2 (base-)modified rna for increasing the expression of a protein |
| 08/05/2009 | EP2083848A1 Method of treatment and prophylaxis |
| 08/05/2009 | EP2006302A9 Protein complex and process for production thereof |
| 08/05/2009 | EP1853227B1 Pharmaceutical composition |
| 08/05/2009 | EP1765394B1 Methods for preparing immunogenic conjugates |
| 08/05/2009 | EP1512014B1 Methods for the identification of all-antigens and their use for cancer therapy and transplantation |
| 08/05/2009 | EP1499735B1 Optimization of transgene expression in mammalian cells |
| 08/05/2009 | EP1430085B1 Leukocyte inactivation module |
| 08/05/2009 | EP1407004B1 Ex-vivo priming for generating cd40-ligand specific cytotoxic t lymphocytes to treat autoimmune and allergic disease |
| 08/05/2009 | EP1367997B1 Injectable water-in-oil emulsions |
| 08/05/2009 | EP1286703B1 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 08/05/2009 | EP1253939B1 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent |
| 08/05/2009 | EP1246913B1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 08/05/2009 | EP1210115B1 DOSAGES FOR TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 08/05/2009 | EP1069907B1 DIAGNOSIS, PREVENTION AND TREATMENT OF ULCERATIVE COLITIS, AND CLINICAL SUBTYPES THEREOF, USING MICROBIAL UC pANCA ANTIGENS |
| 08/05/2009 | EP1029054B1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene |
| 08/05/2009 | EP0981614B1 Prostate cancer-specific marker |
| 08/05/2009 | EP0915980B1 Characterization of granulocytic ehrlichia and methods of use |
| 08/05/2009 | CN101501501A Monoclonal anti-annexin A3 antibodies for the detection of prostate carcinoma |
| 08/05/2009 | CN101501072A Antibody molecules which bind human IL-17 |
| 08/05/2009 | CN101501071A Immune-derived moieties reactive against lysophosphatidic acid |
| 08/05/2009 | CN101501070A Antigenic GM-CSF peptides and antibodies to GM-CSF |
| 08/05/2009 | CN101501069A Protein complex and process for production thereof |
| 08/05/2009 | CN101501058A Process for preparing particles of proteinaceous material |
| 08/05/2009 | CN101500609A Hematopoietic stem cell proliferation promoter |
| 08/05/2009 | CN101500608A Preventive or remedy for inflammatory disease |
| 08/05/2009 | CN101500607A Use of TNFalpha inhibitor for treatment of erosive polyarthritis |
| 08/05/2009 | CN101500606A A direct drug delivery system based on thermally responsive biopolymers |
| 08/05/2009 | CN101500605A Therapeutic methods for treating vascular eye disorders with Dll4 antagonists |
| 08/05/2009 | CN101500604A Plasmids with immunological action |
| 08/05/2009 | CN101500603A Adjuvant-sparing multi-dose influenza vaccination regimen |
| 08/05/2009 | CN101500602A Vaccines and methods for controlling adiposity |
| 08/05/2009 | CN101500601A Expressing hepatitis B virus surface antigen for vaccine preparation |
| 08/05/2009 | CN101500592A Compositions and methods for controlling tissue factor signaling specificity |
| 08/05/2009 | CN101500591A Compositions and methods using same for the detection of viruses |
| 08/05/2009 | CN101500590A Antibodies and related molecules that bind to 161P2F10B proteins |
| 08/05/2009 | CN101498731A Human monoclonal antibody against a costimulatory signal transduction molecule ATLIM and pharmaceutical use thereof |
| 08/05/2009 | CN101497922A Use of PNMA5 gene |
| 08/05/2009 | CN101497891A Novel recombinant viral vector and use thereof |
| 08/05/2009 | CN101497881A Vaccine reading frame crosslinking with human molecule adjuvant hC3d3 same sense mutant |
| 08/05/2009 | CN101497877A Influenza all-virus attenuated live vaccine recombinant, construction method and use thereof |
| 08/05/2009 | CN101497662A TM4SF3 protein for preparing antineoplastic antibody and use thereof |
| 08/05/2009 | CN101497660A Strongylus duodenalis anticoagulant peptide, as well as preparation and use thereof |
| 08/05/2009 | CN101496902A Allergen protecting agent |
| 08/05/2009 | CN101496901A Application of acidic buffer in stable pollen allergen activity |
| 08/05/2009 | CN101496900A Immunity enhancement adjuvant of novel vaccine |
| 08/05/2009 | CN101496899A Prevention, treatment and detection of progressive atrophic rhinitis of pig |
| 08/05/2009 | CN101496898A Vaccine for preventing and/or treating Helicobacter pylori infection |
| 08/05/2009 | CN101496897A Vaccine for fish and application |
| 08/05/2009 | CN100523809C Vaccine for preventing pneumococus infection |
| 08/05/2009 | CN100523192C Vaccines from infectious agents |
| 08/05/2009 | CN100523177C Pig replication and respiration syndrome virus attenuated vaccine strain and uses thereof |
| 08/05/2009 | CN100523176C Transplant acceptance inducing cells of monocytic origin and their preparation and use |